← Back to news
June 5, 2026
FDA Launches Investigation into Mifepristone Safety Amid Political Pressure
- The FDA is conducting a politically charged investigation into mifepristone's safety, expected to take about six months and conclude around April 2024.
- This investigation follows a Louisiana judge's October deadline and is influenced by discussions with anti-abortion groups.
- Despite being on the market for over 25 years, mifepristone's safety is being questioned, with abortion rights advocates criticizing the review as politically motivated.
6 Sources
- The FDA has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and usedJun 5, 2026 at 1:00 AM · WSJ
- FDA launches study of abortion pill safety, WSJ reportsJun 5, 2026 at 2:03 AM · Reuters
- FDA launches safety study for abortion pill mifepristone, source saysJun 5, 2026 at 4:55 AM · CBS News
- FDA reviewing safety of abortion drug mifepristoneJun 5, 2026 at 1:59 PM · The Hill
- RFK Jr’s FDA to study if abortion pill mifepristone is safe despite it being on market for over 25 years: reportJun 5, 2026 at 4:17 PM · Independent
- FDA to review abortion pill safety after sustained GOP ireJun 5, 2026 at 10:56 PM · The Hill